
In late November, the Supreme Court was evaluating whether isolated genes are products of nature, which should not be patented or created by humans, therefore eligible for patent protection. Myriad Genetics, a Utah company holding patents on genes that correlate with increased risk of hereditary breast and ovarian cancer, states that isolated DNA molecules were [...]














